Up‐Regulation of microRNA ‐185‐5p Alleviates Placental Inflammatory Response in Gestational Diabetes Mellitus by Regulating CDC42
The FASEB Journal · 28.02.2026 · 40 (4)
DOI: 10.1096/fj.202503098r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 23.02.2026. Verfasst von Yan Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guiyang Maternal and Child Health Care Hospital, Guizhou Medical University, Guiyang, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Diabetes, Gestational, Placenta, Up-Regulation. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province, National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a common pregnancy‐related disorder characterized by insulin resistance, chronic inflammation, and placental dysfunction. MicroRNAs (miRNAs) are important regulators of placental development and immune homeostasis. This study investigates the role of miR‐185‐5p in GDM‐associated placental inflammation via the CDC42‐JNK/P38 MAPK‐ATF2 pathway. CDC42 was identified as a predicted miR‐185‐5p target using public databases. Placental tissues from GDM patients and controls were analyzed for miR‐185‐5p and CDC42 expression by RT‐qPCR, and direct binding was verified by dual‐luciferase assay. A high‐glucose‐induced HTR8/SVneo trophoblast model was used to test the effects of miR‐185‐5p and CDC42 modulation on proliferation, apoptosis, and cytokine release. In vivo, a GDM mouse model was used to evaluate placental inflammation, structure, and signaling changes after intervention. miR‐185‐5p was downregulated and CDC42 upregulated in GDM placentas, with a significant inverse correlation. miR‐185‐5p directly bound to the 3′‐UTR of CDC42. In high‐glucose‐treated HTR8/SVneo cells, upregulation of miR‐185‐5p or silencing of CDC42 reversed glucose‐induced proliferation inhibition, reduced apoptosis, and suppressed TNF‐α, IL‐6, and IL‐1β levels. In GDM mice, miR‐185‐5p overexpression or CDC42 knockdown significantly reduced placental and serum pro‐inflammatory cytokine expression, suppressed phosphorylation of JNK and P38 MAPK, and downregulated downstream ATF2. miR‐185‐5p targets CDC42 to regulate the JNK/P38 MAPK‐ATF2 pathway, thereby attenuating placental inflammation in GDM. This axis may contribute to the chronic inflammatory mechanisms underlying GDM‐related placental dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guiyang Maternal and Child Health Care Hospital, Guizhou Medical University, Guiyang, People's Republic of China.
- Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
- Guizhou Hospital, The First Affiliated Hospital of Sun Yat-sen University, Guiyang, People's Republic of China.
ORCID-Profile: Yan Zeng, Danqing Zhao
Förderung
- Science and Technology Program of Guizhou Province
- National Natural Science Foundation of China
Zitieren
APA
Zeng, Y., Chen, Q., Yin, L., Yin, X., & Zhao, D. (2026). Up‐Regulation of microRNA ‐185‐5p Alleviates Placental Inflammatory Response in Gestational Diabetes Mellitus by Regulating CDC42. The FASEB Journal, 40(4). https://doi.org/10.1096/fj.202503098r
Vancouver
Zeng Y, Chen Q, Yin L, Yin X, Zhao D. Up‐Regulation of microRNA ‐185‐5p Alleviates Placental Inflammatory Response in Gestational Diabetes Mellitus by Regulating CDC42. The FASEB Journal. 2026;40(4). doi:10.1096/fj.202503098r
BibTeX
@article{Zeng2026,
author = {Zeng, Yan and Chen, Qi and Yin, Li and Yin, Xiaoping and Zhao, Danqing},
title = {Up‐Regulation of microRNA ‐185‐5p Alleviates Placental Inflammatory Response in Gestational Diabetes Mellitus by Regulating CDC42},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {4},
doi = {10.1096/fj.202503098r}
}
EUVIMED